1/13
08:03 am
catx
Perspective Therapeutics (NASDAQ:CATX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $14.00 price target on the stock.
Low
Report
Perspective Therapeutics (NASDAQ:CATX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $14.00 price target on the stock.
1/13
07:22 am
catx
Rating for CATX
Low
Report
Rating for CATX
11/21
11:15 am
catx
Rating for CATX
Medium
Report
Rating for CATX